Key publications
All Publications
- Brouwer Philip J.M., Caniels Tom G., van der Straten Karlijn, Snitselaar Jonne L., Aldon Yoann, Bangaru Sandhya, Torres Jonathan L., Okba Nisreen M.A., Claireaux Mathieu, Kerster Gius, Bentlage Arthur E.H., van Haaren Marlies M., Guerra Denise, Burger Judith A., Schermer Edith E., Verheul Kirsten D., van der Velde Niels, van der Kooi Alex, van Schooten Jelle, van Breemen Mariëlle J., Bijl Tom P.L., Sliepen Kwinten, Aartse Aafke, Derking Ronald, Bontjer Ilja, Kootstra Neeltje A., Joost Wiersinga W., Vidarsson Gestur, Haagmans Bart L., Ward Andrew B., de Bree Godelieve J., Sanders Rogier W., van Gils Marit J. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability Science 2020;369 (6504):643-650 [PubMed]
- van Gils Marit J., van den Kerkhof Tom L. G. M., Ozorowski Gabriel, Cottrell Christopher A., Sok Devin, Pauthner Matthias, Pallesen Jesper, de Val Natalia, Yasmeen Anila, de Taeye Steven W., Schorcht Anna, Gumbs Stephanie, Johanna Inez, Saye-Francisco Karen, Liang Chi-Hui, Landais Elise, Nie Xiaoyan, Pritchard Laura K., Crispin Max, Kelsoe Garnett, Wilson Ian A., Schuitemaker Hanneke, Klasse Per Johan, Moore John P., Burton Dennis R., Ward Andrew B., Sanders Rogier W. An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability Nature microbiology 2016;2 (2):16199 [PubMed]
- Sanders Rogier W., van Gils Marit J., Derking Ronald, Sok Devin, Ketas Thomas J., Burger Judith A., Ozorowski Gabriel, Cupo Albert, Simonich Cassandra, Goo Leslie, Arendt Heather, Kim Helen J., Lee Jeong Hyun, Pugach Pavel, Williams Melissa, Debnath Gargi, Moldt Brian, van Breemen Mariëlle J., Isik Gözde, Medina-Ramírez Max, Back Jaap Willem, Koff Wayne C., Julien Jean-Philippe, Rakasz Eva G., Seaman Michael S., Guttman Miklos, Lee Kelly K., Klasse Per Johan, Labranche Celia, Schief William R., Wilson Ian A., Overbaugh Julie, Burton Dennis R., Ward Andrew B., Montefiori David C., Dean Hansi, Moore John P. HIV-1 neutralizing antibodies induced by native-like envelope trimers Science 2015;349 (6244):aac4223-154 [PubMed]
- McCoy Laura E., van Gils Marit J., Ozorowski Gabriel, Messmer Terrence, Briney Bryan, Voss James E., Kulp Daniel W., Macauley Matthew S., Sok Devin, Pauthner Matthias, Menis Sergey, Cottrell Christopher A., Torres Jonathan L., Hsueh Jessica, Schief William R., Wilson Ian A., Ward Andrew B., Sanders Rogier W., Burton Dennis R. Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies Cell reports 2016;16 (9):2327-2338 [PubMed]
- Sok Devin, van Gils Marit J., Pauthner Matthias, Julien Jean-Philippe, Saye-Francisco Karen L., Hsueh Jessica, Briney Bryan, Lee Jeong Hyun, Le Khoa M., Lee Peter S., Hua Yuanzi, Seaman Michael S., Moore John P., Ward Andrew B., Wilson Ian A., Sanders Rogier W., Burton Dennis R. Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex Proceedings of the National Academy of Sciences of the United States of America 2014;111 (49):17624-17629 [PubMed]
Research programmes
Prof. PhD R.W. Sanders (HIV vaccine research aimed at the induction of neutralizing antibodies)
Current research funding
- AMC (Vrijgesteld)
- NWO
- NWO (Vrijgesteld)
- Stichting Aidsfonds/SOA AIDS Nederland
- ZonMw